Biological cell survival mapping for radiofrequency intracavitary hyperthermia combined with simultaneous high dose-rate intracavitary irradiation

Jpn J Cancer Res. 2001 Jan;92(1):95-102. doi: 10.1111/j.1349-7006.2001.tb01053.x.

Abstract

We examined the best way to combine recently developed radiofrequency intracavitary hyperthermia with simultaneous high dose-rate intracavitary brachytherapy in an original experimental model. Temperature distribution was measured with an experimental phantom which was immersed in a water bath with the temperature controlled at 37 degrees C. Radiation dose distribution was calculated with a treatment-planning computer. Cell survival was measured by colony assay with HeLa-TG cells in vitro. Radiation dose response at 1 - 7 Gy and time response with hyperthermia in the range of 40 - 46 degrees C were estimated. Radiation dose-response curves in simultaneous treatment with hyperthermia for 30 min at 37 to 46 degrees C were estimated and the surviving fractions in combined treatment were plotted against temperature. For intracavitary radiation alone, cell survival rates increased with increasing distance from the source. For intracavitary hyperthermia alone, the maximum temperature was observed at a depth of 13 mm from the surface of the applicator under suitable treatment conditions. Homogeneous cell killing from the surface of the applicator to a tumor depth of 13 mm was observed under a specific treatment condition. Our experimental model is useful for evaluating the best simultaneous combined treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brachytherapy / methods*
  • Cell Survival / physiology*
  • Combined Modality Therapy / methods
  • Dose-Response Relationship, Radiation
  • HeLa Cells
  • Humans
  • Hyperthermia, Induced / methods*
  • Neoplasms / therapy*
  • Phantoms, Imaging
  • Radiotherapy Dosage
  • Reference Values